Joseph C. Papa brings over 35 years of experience in the healthcare and pharmaceutical industry. Mr. Papa was named Chief Executive Officer at Emergent BioSolutions in February 2024. He recently served as CEO and chairman at Bausch and Lomb Corporation. Prior to his role at Bausch and Lomb, Mr. Papa was the CEO and chairman of Bausch Health, now Bausch Health Companies Inc. He also served as chairman and CEO of Perrigo, and held leadership positions at Cardinal Health, Watson Pharmaceuticals and Novartis.

He currently is the chairman of the board of SparingVision, a privately held genomic medicines company, and is a member of the board of directors of Candel Therapeutics. He also served as a member of the board of directors of Prometheus Biosciences (acquired by Merck in 2023).